Expanding the application of its ultrafiltration technology to pediatric patients represents a strategic move by Nuwellis to tap into a new patient demographic. This could lead to increased product adoption and usage, potentially boosting the company's revenues and market presence in the healthcare sector. The focus on pediatric care also aligns with corporate responsibility goals, enhancing the company's image and potentially attracting positive attention from investors and customers alike.